BRD2 and polycystic ovary syndrome: For all PCOS patients with a LH/FSH ratio ≥ 2 (149 cycles in the GnRH agonist protocol and 23 cycles in the mild stimulation protocol), there was no statistical difference in the comparison of demographic properties and COH process index between the two groups.